Veterinary Anti-infectives Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2028

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Veterinary Anti-infectives Market, By Animal Type

7.1.  Veterinary Anti-infectives Market, By Animal Type, 2020-2028

7.1.1.    Livestock

7.1.1.1.        Market Revenue and Forecast (2016-2028)

7.1.2.    Companion animal

7.1.2.1.        Market Revenue and Forecast (2016-2028)

Chapter 8.  Global Veterinary Anti-infectives Market, By Product Type

8.1.  Veterinary Anti-infectives Market, By Product Type, 2020-2028

8.1.1.    Antibacterial

8.1.1.1.        Market Revenue and Forecast (2016-2028)

8.1.2.    Antifungals

8.1.2.1.        Market Revenue and Forecast (2016-2028)

8.1.3.    Antivirals

8.1.3.1.        Market Revenue and Forecast (2016-2028)

8.1.4.    Others

8.1.4.1.        Market Revenue and Forecast (2016-2028)

Chapter 9.  Global Veterinary Anti-infectives Market, By Route of Administration

9.1.  Veterinary Anti-infectives Market, By Route of Administration, 2020-2028

9.1.1.    Oral

9.1.1.1.        Market Revenue and Forecast (2016-2028)

9.1.2.    Injectables

9.1.2.1.        Market Revenue and Forecast (2016-2028)

9.1.3.    Others

9.1.3.1.        Market Revenue and Forecast (2016-2028)

Chapter 10.      Global Veterinary Anti-infectives Market, By Distribution Channel

10.1.        Veterinary Anti-infectives Market, By Distribution Channel, 2020-2028

10.1.1.  Veterinary Clinics

10.1.1.1.      Market Revenue and Forecast (2016-2028)

10.1.2.  Retail Pharmacies

10.1.2.1.      Market Revenue and Forecast (2016-2028)

10.1.3.  E-commerce

10.1.3.1.      Market Revenue and Forecast (2016-2028)

Chapter 11.      Global Veterinary Anti-infectives Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, By Animal Type (2016-2028)

11.1.2.  Market Revenue and Forecast, By Product Type (2016-2028)

11.1.3.  Market Revenue and Forecast, By Route of Administration (2016-2028)

11.1.4.  Market Revenue and Forecast, By Distribution Channel (2016-2028)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, By Animal Type (2016-2028)

11.1.5.2.      Market Revenue and Forecast, By Product Type (2016-2028)

11.1.5.3.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.1.5.4.      Market Revenue and Forecast, By Distribution Channel (2016-2028)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, By Animal Type (2016-2028)

11.1.6.2.      Market Revenue and Forecast, By Product Type (2016-2028)

11.1.6.3.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.1.6.4.      Market Revenue and Forecast, By Distribution Channel (2016-2028)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, By Animal Type (2016-2028)

11.2.2.  Market Revenue and Forecast, By Product Type (2016-2028)

11.2.3.  Market Revenue and Forecast, By Route of Administration (2016-2028)

11.2.4.  Market Revenue and Forecast, By Distribution Channel (2016-2028)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, By Animal Type (2016-2028)

11.2.5.2.      Market Revenue and Forecast, By Product Type (2016-2028)

11.2.5.3.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.2.5.4.      Market Revenue and Forecast, By Distribution Channel (2016-2028)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, By Animal Type (2016-2028)

11.2.6.2.      Market Revenue and Forecast, By Product Type (2016-2028)

11.2.6.3.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.2.6.4.      Market Revenue and Forecast, By Distribution Channel (2016-2028)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, By Animal Type (2016-2028)

11.2.7.2.      Market Revenue and Forecast, By Product Type (2016-2028)

11.2.7.3.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.2.7.4.      Market Revenue and Forecast, By Distribution Channel (2016-2028)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, By Animal Type (2016-2028)

11.2.8.2.      Market Revenue and Forecast, By Product Type (2016-2028)

11.2.8.3.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.2.8.4.      Market Revenue and Forecast, By Distribution Channel (2016-2028)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, By Animal Type (2016-2028)

11.3.2.  Market Revenue and Forecast, By Product Type (2016-2028)

11.3.3.  Market Revenue and Forecast, By Route of Administration (2016-2028)

11.3.4.  Market Revenue and Forecast, By Distribution Channel (2016-2028)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, By Animal Type (2016-2028)

11.3.5.2.      Market Revenue and Forecast, By Product Type (2016-2028)

11.3.5.3.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.3.5.4.      Market Revenue and Forecast, By Distribution Channel (2016-2028)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, By Animal Type (2016-2028)

11.3.6.2.      Market Revenue and Forecast, By Product Type (2016-2028)

11.3.6.3.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.3.6.4.      Market Revenue and Forecast, By Distribution Channel (2016-2028)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, By Animal Type (2016-2028)

11.3.7.2.      Market Revenue and Forecast, By Product Type (2016-2028)

11.3.7.3.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.3.7.4.      Market Revenue and Forecast, By Distribution Channel (2016-2028)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, By Animal Type (2016-2028)

11.3.8.2.      Market Revenue and Forecast, By Product Type (2016-2028)

11.3.8.3.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.3.8.4.      Market Revenue and Forecast, By Distribution Channel (2016-2028)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, By Animal Type (2016-2028)

11.4.2.  Market Revenue and Forecast, By Product Type (2016-2028)

11.4.3.  Market Revenue and Forecast, By Route of Administration (2016-2028)

11.4.4.  Market Revenue and Forecast, By Distribution Channel (2016-2028)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, By Animal Type (2016-2028)

11.4.5.2.      Market Revenue and Forecast, By Product Type (2016-2028)

11.4.5.3.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.4.5.4.      Market Revenue and Forecast, By Distribution Channel (2016-2028)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, By Animal Type (2016-2028)

11.4.6.2.      Market Revenue and Forecast, By Product Type (2016-2028)

11.4.6.3.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.4.6.4.      Market Revenue and Forecast, By Distribution Channel (2016-2028)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, By Animal Type (2016-2028)

11.4.7.2.      Market Revenue and Forecast, By Product Type (2016-2028)

11.4.7.3.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.4.7.4.      Market Revenue and Forecast, By Distribution Channel (2016-2028)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, By Animal Type (2016-2028)

11.4.8.2.      Market Revenue and Forecast, By Product Type (2016-2028)

11.4.8.3.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.4.8.4.      Market Revenue and Forecast, By Distribution Channel (2016-2028)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, By Animal Type (2016-2028)

11.5.2.  Market Revenue and Forecast, By Product Type (2016-2028)

11.5.3.  Market Revenue and Forecast, By Route of Administration (2016-2028)

11.5.4.  Market Revenue and Forecast, By Distribution Channel (2016-2028)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, By Animal Type (2016-2028)

11.5.5.2.      Market Revenue and Forecast, By Product Type (2016-2028)

11.5.5.3.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.5.5.4.      Market Revenue and Forecast, By Distribution Channel (2016-2028)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, By Animal Type (2016-2028)

11.5.6.2.      Market Revenue and Forecast, By Product Type (2016-2028)

11.5.6.3.      Market Revenue and Forecast, By Route of Administration (2016-2028)

11.5.6.4.      Market Revenue and Forecast, By Distribution Channel (2016-2028)

Chapter 12.  Company Profiles

12.1.              Zoetis, Inc.

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Boehringer Ingelheim GmbH

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Ceva Santé Animale

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              Vetoquinol S.A.

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Merck & Co., Inc.

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              Phibro Animal Health Corporation;

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

Glossary of Terms

Report Details

  • Report Code:36822
  • Category:Healthcare
  • No. of Pages:250
  • Format:PDF/PPT/Excel
  • Published:January 2021
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers